USMF logo

Institutional Repository in Medical Sciences
of Nicolae Testemitanu State University of Medicine and Pharmacy
of the Republic of Moldova
(IRMS – Nicolae Testemitanu SUMPh)

Biblioteca Stiintifica Medicala
DSpace

University homepage  |  Library homepage

 
 
Please use this identifier to cite or link to this item: http://hdl.handle.net/20.500.12710/18490
Full metadata record
DC FieldValueLanguage
dc.contributor.authorCotorobai, lulia-
dc.date.accessioned2021-11-15T10:58:26Z-
dc.date.available2021-11-15T10:58:26Z-
dc.date.issued2014-
dc.identifier.citationCOTOROBAI, lulia. The treatment of pain to oncological patients. In: MedEspera: the 5th Internat. Medical Congress for Students and Young Doctors: abstract book. Chișinău: S. n., 2014, pp. 114-115.en_US
dc.identifier.urihttp://repository.usmf.md/handle/20.500.12710/18490-
dc.descriptionState University of Medicine and Pharmacy “Nicolae Testemitanu”, Department of Hematology, Oncology and Therapy Campaign, Discipline of Oncology, Chisinau, Republic of Moldovaen_US
dc.description.abstractIntroduction: Cancer pain may be due to the disease itself or can result from the treatment, including surgery, radiation therapy and chemotherapy. Although usually occurs relatively late in the natural history of the disease, the most common symptom is pain in the cancer present in 30- 40% of patients at diagnosis from 40-70% to 70-90% at baseline and during phase terminals. The prevalence of pain depends on the type of tumor, ranging from 52% in patients with lung cancers and up to 5% in patients with leukemia. Purpose and Objectives: The evaluation and appreciation of chronic pain in oncological pathology Materials and methods: The study conducted on a group of 50 patients from October 2013 to January using the Brief Pain Inventory (BPI). Results: The group studied consisted of women 44%, men 56%. BPI is a numerical scale of 0-10 assessing the degree of pain interference with the normal activities of the patient which it applies, to which is added information on the gradation of the pain, the pain at the time of examination. Starting from the order established after evaluation of maximum intensity of the pain score 6-30%, followed by the score 8-15%, scores 9 and 10 - 10-12%. When assessing the minimum level of pain intensity score of 2 to 23% and score 4 to 20 %, which ranks the most frequently encountered in patients investigated. Usual level of pain intensity score highlights the prevalence of 6 and 8 with 20%, followed by the score 5 to 18%, the other scores were determined from a minimum of patients. Depending on the type of treatment: 79% were receiving chemotherapy, chemo-radiotherapeutic treatment 5%, hormone therapy 2% and unspecified 14%. According to the step by step antalgic treatment, elaborated by WHO: analgesic stage administered -7% stage I, stage II- 23% and stage III - 70 %. Conclusion: Analyzing all the features of chronic pain by using the BPI questionnaire in the study of cancer patients, we determined that although in theory the current therapeutic methods and applying rational (W HO principles) would allow excellent results in almost 95% of patients, but cancer pain remains untreated satisfactory in many situations.en_US
dc.language.isoenen_US
dc.publisherMinistry of Health of the Republic of Moldova, State Medical and Pharmaceutical University Nicolae Testemitanu, Medical Students and Residents Associationen_US
dc.relation.ispartofMedEspera: The 5th International Medical Congress for Students and Young Doctors, May 14-17, 2014, Chisinau, Republic of Moldovaen_US
dc.subjectPainen_US
dc.subjectscoreen_US
dc.titleThe treatment of pain to oncological patientsen_US
dc.typeOtheren_US
Appears in Collections:MedEspera 2014

Files in This Item:
File Description SizeFormat 
THE_TREATMENT_OF_PAIN_TO_ONCOLOGICAL_PATIENTS.pdf123.31 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

 

Valid XHTML 1.0! DSpace Software Copyright © 2002-2013  Duraspace - Feedback